235 related articles for article (PubMed ID: 15588226)
1. Human high molecular weight-melanoma-associated antigen (HMW-MAA): a melanoma cell surface chondroitin sulfate proteoglycan (MSCP) with biological and clinical significance.
Campoli MR; Chang CC; Kageshita T; Wang X; McCarthy JB; Ferrone S
Crit Rev Immunol; 2004; 24(4):267-96. PubMed ID: 15588226
[TBL] [Abstract][Full Text] [Related]
2. Characterization of human anti-high molecular weight-melanoma-associated antigen single-chain Fv fragments isolated from a phage display antibody library.
Desai SA; Wang X; Noronha EJ; Kageshita T; Ferrone S
Cancer Res; 1998 Jun; 58(11):2417-25. PubMed ID: 9622083
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy of melanoma targeting human high molecular weight melanoma-associated antigen: potential role of nonimmunological mechanisms.
Chang CC; Campoli M; Luo W; Zhao W; Zaenker KS; Ferrone S
Ann N Y Acad Sci; 2004 Dec; 1028():340-50. PubMed ID: 15650259
[TBL] [Abstract][Full Text] [Related]
4. Functional and clinical relevance of chondroitin sulfate proteoglycan 4.
Campoli M; Ferrone S; Wang X
Adv Cancer Res; 2010; 109():73-121. PubMed ID: 21070915
[TBL] [Abstract][Full Text] [Related]
5. Cancer immunotherapy targeting the high molecular weight melanoma-associated antigen protein results in a broad antitumor response and reduction of pericytes in the tumor vasculature.
Maciag PC; Seavey MM; Pan ZK; Ferrone S; Paterson Y
Cancer Res; 2008 Oct; 68(19):8066-75. PubMed ID: 18829565
[TBL] [Abstract][Full Text] [Related]
6. Epitope distance to the target cell membrane and antigen size determine the potency of T cell-mediated lysis by BiTE antibodies specific for a large melanoma surface antigen.
Bluemel C; Hausmann S; Fluhr P; Sriskandarajah M; Stallcup WB; Baeuerle PA; Kufer P
Cancer Immunol Immunother; 2010 Aug; 59(8):1197-209. PubMed ID: 20309546
[TBL] [Abstract][Full Text] [Related]
7. Targeting melanoma cells with human high molecular weight-melanoma associated antigen-specific antibodies elicited by a peptide mimotope: functional effects.
Luo W; Ko E; Hsu JC; Wang X; Ferrone S
J Immunol; 2006 May; 176(10):6046-54. PubMed ID: 16670313
[TBL] [Abstract][Full Text] [Related]
8. Human high molecular weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: induction of humoral anti-HMW-MAA immunity and prolongation of survival in patients with stage IV melanoma.
Mittelman A; Chen ZJ; Yang H; Wong GY; Ferrone S
Proc Natl Acad Sci U S A; 1992 Jan; 89(2):466-70. PubMed ID: 1731316
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of the immune response and regression of metastatic lesions following development of humoral anti-high molecular weight-melanoma associated antigen immunity in three patients with advanced malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23.
Mittelman A; Chen ZJ; Liu CC; Hirai S; Ferrone S
Cancer Res; 1994 Jan; 54(2):415-21. PubMed ID: 8275478
[TBL] [Abstract][Full Text] [Related]
10. Targeting 11q23 positive acute leukemia cells with high molecular weight-melanoma associated antigen-specific monoclonal antibodies.
Drake AS; Brady MT; Wang XH; Sait SJ; Earp JC; Ghoshal Gupta S; Ferrone S; Wang ES; Wetzler M
Cancer Immunol Immunother; 2009 Mar; 58(3):415-27. PubMed ID: 18677475
[TBL] [Abstract][Full Text] [Related]
11. Melanoma proteoglycan modifies gene expression to stimulate tumor cell motility, growth, and epithelial-to-mesenchymal transition.
Yang J; Price MA; Li GY; Bar-Eli M; Salgia R; Jagedeeswaran R; Carlson JH; Ferrone S; Turley EA; McCarthy JB
Cancer Res; 2009 Oct; 69(19):7538-47. PubMed ID: 19738072
[TBL] [Abstract][Full Text] [Related]
12. Redirected lysis of human melanoma cells by a MCSP/CD3-bispecific BiTE antibody that engages patient-derived T cells.
Torisu-Itakura H; Schoellhammer HF; Sim MS; Irie RF; Hausmann S; Raum T; Baeuerle PA; Morton DL
J Immunother; 2011 Oct; 34(8):597-605. PubMed ID: 21904216
[TBL] [Abstract][Full Text] [Related]
13. The expression of human high molecular weight melanoma-associated antigen in acral lentiginous melanoma.
Nishi H; Inoue Y; Kageshita T; Takata M; Ihn H
Biosci Trends; 2010 Apr; 4(2):86-9. PubMed ID: 20448346
[TBL] [Abstract][Full Text] [Related]
14. Melanoma chondroitin sulphate proteoglycan regulates cell spreading through Cdc42, Ack-1 and p130cas.
Eisenmann KM; McCarthy JB; Simpson MA; Keely PJ; Guan JL; Tachibana K; Lim L; Manser E; Furcht LT; Iida J
Nat Cell Biol; 1999 Dec; 1(8):507-13. PubMed ID: 10587647
[TBL] [Abstract][Full Text] [Related]
15. Analysis with monoclonal antibodies of the molecular and cellular heterogeneity of human high molecular weight melanoma associated antigen.
Ziai MR; Imberti L; Nicotra MR; Badaracco G; Segatto O; Natali PG; Ferrone S
Cancer Res; 1987 May; 47(9):2474-80. PubMed ID: 3552215
[TBL] [Abstract][Full Text] [Related]
16. CD4-dependent potentiation of a high molecular weight-melanoma-associated antigen-specific CTL response elicited in HLA-A2/Kb transgenic mice.
Peng L; Ko E; Luo W; Wang X; Shrikant PA; Ferrone S
J Immunol; 2006 Feb; 176(4):2307-15. PubMed ID: 16455987
[TBL] [Abstract][Full Text] [Related]
17. Regulation of high molecular weight-melanoma associated antigen (HMW-MAA) gene expression by promoter DNA methylation in human melanoma cells.
Luo W; Wang X; Kageshita T; Wakasugi S; Karpf AR; Ferrone S
Oncogene; 2006 May; 25(20):2873-84. PubMed ID: 16407841
[TBL] [Abstract][Full Text] [Related]
18. Association of high molecular weight melanoma-associated antigen expression in primary acral lentiginous melanoma lesions with poor prognosis.
Kageshita T; Kuriya N; Ono T; Horikoshi T; Takahashi M; Wong GY; Ferrone S
Cancer Res; 1993 Jun; 53(12):2830-3. PubMed ID: 8504426
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of melanoma associated antigens in acral lentiginous melanoma and in nodular melanoma lesions.
Kageshita T; Nakamura T; Yamada M; Kuriya N; Arao T; Ferrone S
Cancer Res; 1991 Mar; 51(6):1726-32. PubMed ID: 1671829
[TBL] [Abstract][Full Text] [Related]
20. Cell surface CD44-related chondroitin sulfate proteoglycan is required for transforming growth factor-beta-stimulated mouse melanoma cell motility and invasive behavior on type I collagen.
Faassen AE; Mooradian DL; Tranquillo RT; Dickinson RB; Letourneau PC; Oegema TR; McCarthy JB
J Cell Sci; 1993 Jun; 105 ( Pt 2)():501-11. PubMed ID: 7691842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
